TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22100213

Group type: EXPERIMENTAL
Intervention: Continuous thoracic epidural bupivacaine with hydromorphone
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Continuous thoracic epidural bupivacaine without hydromorphone
Number of subjects: 75

Group type: COMPARATOR
Intervention: Continuous paravertebral infusion of bupivacaine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Incentive spirometry in epidural bupivacaine with hydromorphone group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Incentive spirometry in epidural bupivacaine alone and continuous paravertebral infusion of bupivacaine
Number of subjects: 75
Study: 20206845

Group type: EXPERIMENTAL
Intervention: Electrical nerve stimulation (Group 1, n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fascial pop technique (Group 2, n = 50)
Number of subjects: 100
Study: 17493194

Group type: EXPERIMENTAL
Intervention: Higher bone mineral density (BMD)
Number of subjects: 1042

Group type: EXPERIMENTAL
Intervention: Highest quartile of BMD
Number of subjects: 1042

Group type: COMPARATOR
Intervention: Lowest three quartiles of BMD combined
Number of subjects: 1042
Study: 15579581

Group type: EXPERIMENTAL
Intervention: Prolonged vibration applied to the Achilles tendon at 100 Hz for 30 min
Number of subjects: 13
Study: 12099976

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG) 4 mg/day
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 10442726

Group type: EXPERIMENTAL
Intervention: Augmented surgery (group A)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Prism adaptation (group P)
Number of subjects: 43
Study: 7793717

Group type: EXPERIMENTAL
Intervention: Spine board with air mattress
Number of subjects: 20

Group type: COMPARATOR
Intervention: Spine board without air mattress
Number of subjects: 20
Study: 2254510

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Negative response
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Nonresponse
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Positive response
Number of subjects: 62
Study: 382150

Group type: EXPERIMENTAL
Intervention: Domperidone (10 mg t.d.s.)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 31596719

Group type: EXPERIMENTAL
Intervention: Surgical sealant
Number of subjects: 100
Study: 28668243

Group type: EXPERIMENTAL
Intervention: Misoprostol (200 μg) administered at 30 minutes, 90 minutes, and 4 hours after the first dose of nasal ketorolac
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: COMPARATOR
Intervention: Historical controls
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 45
Study: 26147654

Group type: EXPERIMENTAL
Intervention: Specialty high amylose white rice 2 (Rondo)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Specialty high amylose white rice 1 (Dixiebelle)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Short grain rice
Number of subjects: 18
Study: 23480968

Group type: EXPERIMENTAL
Intervention: Telephone-based follow-up counseling (FC) with 5 telephone contacts over a 2-month period.
Number of subjects: 928

Group type: COMPARATOR
Intervention: Multi-component intervention program (MC) without telephone follow-up counseling.
Number of subjects: 928
Study: 21813850

Group type: EXPERIMENTAL
Intervention: Mass azithromycin treatment
Number of subjects: 0
Study: 19661847

Group type: EXPERIMENTAL
Intervention: Bacteriophage treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 42
Study: 16310932

Group type: EXPERIMENTAL
Intervention: Transobturator route (TOR)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Retropubic route (RPR)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study: 14602361

Group type: COMPARATOR
Intervention: Placebo level of alcohol (0.04 g/kg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol (0.40 g/kg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Higher dose of alcohol (0.80 g/kg)
Number of subjects: 45
Study: 10717252

Group type: EXPERIMENTAL
Intervention: Certoparin (low molecular weight heparin)
Number of subjects: 324

Group type: COMPARATOR
Intervention: UF heparin (unfractionated heparin)
Number of subjects: 324
Study: 8827423

Group type: EXPERIMENTAL
Intervention: Epinephrine infusion
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 24
Study: 1400008

Group type: EXPERIMENTAL
Intervention: Protein supplementation (PROIN) at 2.62 g.kg‐1.day‐1
Number of subjects: 12

Group type: COMPARATOR
Intervention: Carbohydrate supplementation (CHO) at 1.35 g.kg‐1.day‐1
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Recommended protein intake
Number of subjects: 12
Study: 3155548

Group type: EXPERIMENTAL
Intervention: Intra-arterial floxuridine
Number of subjects: 35
Study: 31642725

Group type: EXPERIMENTAL
Intervention: Abdominal binding alone
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Combination therapy (exercise therapy + abdominal binding)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 32
Study: 31100345

Group type: EXPERIMENTAL
Intervention: Anodal stimulation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 73
Study: 29410375

Group type: EXPERIMENTAL
Intervention: Catheter Group (N = 43)
Number of subjects: 85

Group type: COMPARATOR
Intervention: No-Catheter Group (N = 42)
Number of subjects: 85
Study: 26460695

Group type: EXPERIMENTAL
Intervention: Sinovac Enterovirus 71 vaccine
Number of subjects: 10077

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10077
Study: 24879494

Group type: EXPERIMENTAL
Intervention: 100,000 units oral vitamin D3 every 3 months for 1 year
Number of subjects: 75

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 75
Study: 20974667

Group type: EXPERIMENTAL
Intervention: Covariate-adjusted response-adaptive randomisation procedure using log-odds ratio within the Bayesian framework for longitudinal binary responses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Urn design by Biswas and Dewanji
Number of subjects: 0
Study: 20129178

Group type: EXPERIMENTAL
Intervention: Homeopathic simillimum
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 17568152

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 0.5 mg/kg/12 h for 9 days, then HC 0.5 mg/kg/24 h for 3 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC)
Number of subjects: 50
Study: 16280447

Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg) + Vitamin D3 (200 IU)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Cheese (1000 mg calcium)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study: 12123334

Group type: EXPERIMENTAL
Intervention: Accelerated infusional ECF with G-CSF support
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional infusional ECF
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 27
Study: 11498911

Group type: EXPERIMENTAL
Intervention: Shenshuailing Kou Fu Ye (SKFY)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Shenshuailing Guan Chang Ye (SGCY)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coateg aldehyde oxystarch
Number of subjects: 0
Study: 9691864

Group type: EXPERIMENTAL
Intervention: 0.9% saline 1000 ml i.v. over a 30‐min period
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydroxyethyl starch (200/0.5) 1000 ml i.v. over a 30‐min period
Number of subjects: 0
Study: 7875275

Group type: EXPERIMENTAL
Intervention: Shuttle walking test
Number of subjects: 29
Study: 3278726

Group type: EXPERIMENTAL
Intervention: 24 h bed rest
Number of subjects: 80

Group type: COMPARATOR
Intervention: Early (6 h post spinal) mobilization
Number of subjects: 80
Study: 28971287

Group type: EXPERIMENTAL
Intervention: RCS diet (raw cornstarch)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Basal diet (without starch)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence or absence of dietary carbohydrates (CBH)
Number of subjects: 0
Study: 29231344

Group type: EXPERIMENTAL
Intervention: Drug oil moxibustion
Number of subjects: 120

Group type: COMPARATOR
Intervention: Simple moxibustion
Number of subjects: 120

Group type: COMPARATOR
Intervention: Western medication (tamsulosin hydrochloride)
Number of subjects: 120
Study: 26231378

Group type: EXPERIMENTAL
Intervention: Unilateral impact exercise targeting the total hip and lumbar spine (n = 42 pairs)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Unilateral impact exercise targeting the distal radius (n = 24 pairs)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 107
Study: 24001253

Group type: EXPERIMENTAL
Intervention: Walkstations (treadmills attached to desks) with feedback on usage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Information on coworkers' usage levels
Number of subjects: 0
Study: 20595146

Group type: EXPERIMENTAL
Intervention: SiNQ-5 questionnaire (self-administered, scoring 0-10 points)
Number of subjects: 125
Study: 19201677

Group type: EXPERIMENTAL
Intervention: Face-to-face interview
Number of subjects: 818

Group type: COMPARATOR
Intervention: Audio computer-assisted self-interview (audio-CASI)
Number of subjects: 818
Study: 17217214

Group type: EXPERIMENTAL
Intervention: Desensitizing toothpaste containing EMS salts
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo toothpaste (without any therapeutic agents)
Number of subjects: 40
Study: 14623801

Group type: EXPERIMENTAL
Intervention: Preprocedural soluble CD40L (sCD40L) levels
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: High preprocedural sCD40L
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: In vitro stimulation with serum from patients with high sCD40L
Number of subjects: 70
Study: 10757545

Group type: EXPERIMENTAL
Intervention: 400 mg DHA/d for 3 months
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 800 mg DHA/d for 3 months
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (0 mg DHA/d for 3 months)
Number of subjects: 28
Study: 8827810

Group type: EXPERIMENTAL
Intervention: Azelastine administered orally twice a day
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no azelastine)
Number of subjects: 48
Study: 1424413

Group type: EXPERIMENTAL
Intervention: L-654,066 (0.1 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: L-654,066 (0.5 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: L-654,066 (1 to 25 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: L-654,066 (50 to 100 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 29350278

Group type: EXPERIMENTAL
Intervention: Lower body resistance training with blood flow restriction (BFR) at 60% limb occlusion pressure
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-BFR control group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lower body resistance training with blood flow restriction (BFR)
Number of subjects: 24
Study: 27400292

Group type: EXPERIMENTAL
Intervention: Scoring balloon predilation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional balloon predilation
Number of subjects: 52
Study: 24338864

Group type: EXPERIMENTAL
Intervention: Baseline measures of mental health and health insurance status
Number of subjects: 432
Study: 23141372

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Ziprasidone and Olanzapine
Number of subjects: 94
Study: 20159249

Group type: EXPERIMENTAL
Intervention: omalizumab
Number of subjects: 248

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 248
Study: 19299087

Group type: EXPERIMENTAL
Intervention: Brief intervention (1-session advice or motivational interviewing)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Extended intervention (10 sessions motivational interviewing/cognitive-behavior therapy)
Number of subjects: 248
Study: 16476697

Group type: EXPERIMENTAL
Intervention: Patient-controlled cervical epidural fentanyl (PCA-Epid group, n=20)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Patient-controlled i.v. fentanyl (PCA-IV group, n=22)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Patient-controlled cervical epidural fentanyl (PCA-Epid group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Patient-controlled i.v. fentanyl (PCA-IV group)
Number of subjects: 42
Study: 14508601

Group type: EXPERIMENTAL
Intervention: Pool-based exercise
Number of subjects: 50

Group type: COMPARATOR
Intervention: Balneotherapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 50
Study: 11420782

Group type: EXPERIMENTAL
Intervention: Cholecalciferol treatment (800 IU daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo preparation
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cholecalciferol treatment
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Seasonal effect analysis
Number of subjects: 70
Study: 9250233

Group type: EXPERIMENTAL
Intervention: Nicotine inhalers
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo inhalers
Number of subjects: 247
Study: 8513518

Group type: EXPERIMENTAL
Intervention: Diclofenac (50 mg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 3646615

Group type: EXPERIMENTAL
Intervention: Increased age
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: DNR orders
Number of subjects: 364
Study: 27287612

Group type: EXPERIMENTAL
Intervention: Standard artemether-lumefantrine (AL) regimen + 0.25 mg/kg single-dose of primaquine (PQ)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Standard artemether-lumefantrine (AL) regimen
Number of subjects: 220
Study: 24450819

Group type: EXPERIMENTAL
Intervention: Targeted temperature management to moderate hypothermia (32-34°C) for 72 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Targeted temperature management to normothermia (36-37°C) for 72 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted temperature management to moderate hypothermia (32-34°C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Targeted temperature management to normothermia (36-37°C)
Number of subjects: 0
Study: 22100962

Group type: EXPERIMENTAL
Intervention: Discussions about burden of treatment (BOT) during clinical visits
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Discussions about monitoring, treatment administration, access, and treatment effects
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Addressing burden of treatment (BOT)
Number of subjects: 46
Study: 19397539

Group type: EXPERIMENTAL
Intervention: 20% glucose infusion
Number of subjects: 121

Group type: COMPARATOR
Intervention: 15% glucose infusion
Number of subjects: 121
Study: 19702752

Group type: EXPERIMENTAL
Intervention: Levetiracetam (20-60 mg/kg/day)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 99
Study: 15845670

Group type: EXPERIMENTAL
Intervention: SAB+REMI (Spinal Anesthetic Blockade with Remifentanil)
Number of subjects: 45

Group type: COMPARATOR
Intervention: REMI (Remifentanil without Spinal Anesthetic Blockade)
Number of subjects: 45
Study: 12875347

Group type: EXPERIMENTAL
Intervention: Lisinopril/hydrochlorothiazide (20 mg/12.5 mg)
Number of subjects: 24
Study: 10484594

Group type: EXPERIMENTAL
Intervention: Variable-Intensity (VI) exercise
Number of subjects: 6

Group type: COMPARATOR
Intervention: Constant-Load (SS) exercise
Number of subjects: 6
Study: 8753675

Group type: EXPERIMENTAL
Intervention: Vasoactivation with acetazolamide
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Neuroactivation by labyrinth task
Number of subjects: 80
Study: 1878244

Group type: EXPERIMENTAL
Intervention: 0.1% dimetindene gel
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 6798903

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 10
Study: 30508141

Group type: EXPERIMENTAL
Intervention: cCBT (computerized cognitive behavioral therapy) intervention, Beating the Blues, with care coach support for eight sessions
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: cCBT (computerized cognitive behavioral therapy) intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 30
Study: 30722757

Group type: EXPERIMENTAL
Intervention: Chair-based aerobic exercises (CAE, n = 19)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Chair-based elastic-band strength exercises (CSE, n = 15)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (CG, n = 13)
Number of subjects: 47
Study: 28106355

Group type: EXPERIMENTAL
Intervention: Fiberoptic-guided intubation (FGI)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intubating laryngeal mask airway assisted intubation (ILMA-AI)
Number of subjects: 32
Study: 26013537

Group type: COMPARATOR
Intervention: Tobacco only intervention (n=199)
Number of subjects: 620

Group type: COMPARATOR
Intervention: Alcohol only intervention (n=206)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Integrated alcohol and tobacco intervention (n=215)
Number of subjects: 620

Group type: COMPARATOR
Intervention: Control group (tobacco only intervention)
Number of subjects: 620

Group type: COMPARATOR
Intervention: Control group (alcohol only intervention)
Number of subjects: 620
Study: 23212677

Group type: EXPERIMENTAL
Intervention: Structured intervention consisting of psychoeducation and cognitive behavioral therapy (6 one-hour sessions with a psychologist)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 56
Study: 21321787

Group type: EXPERIMENTAL
Intervention: Job maintenance training program
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 122
Study: 19477443

Group type: EXPERIMENTAL
Intervention: Intraperitoneal instillation of 120 mg of lidocaine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 75
Study: 16927437

Group type: EXPERIMENTAL
Intervention: Unmatched analysis on data from matched-pair design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalized linear model approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-stage cluster-level analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalized estimating equations
Number of subjects: 0
Study: 13678227

Group type: EXPERIMENTAL
Intervention: 1% Fennel extract cream
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 2% Fennel extract cream
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (0% Fennel extract cream)
Number of subjects: 38
Study: 10633537

Group type: EXPERIMENTAL
Intervention: Type I diabetic patients with history of recurrent severe hypoglycaemia
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Type I diabetic patients without history of severe hypoglycaemia
Number of subjects: 41

Group type: COMPARATOR
Intervention: Non-diabetic controls
Number of subjects: 41
Study: 9192125

Group type: EXPERIMENTAL
Intervention: Random urine testing for performance enhancing drugs (anabolic steroids, diuretics, caffeine, peptide hormones, pseudoephedrine, probenecid, methoxyphenamine, dextropropoxyphene)
Number of subjects: 900
Study: 1300947

Group type: EXPERIMENTAL
Intervention: Topical antibiotics (latamoxef, cefmenoxime, cefotiam, cefamandole) administered during operation at a dose of 1 or 2 g
Number of subjects: 80

Group type: COMPARATOR
Intervention: Systemic antibiotics (cefem antibiotics) administered by intravenous drip at a dose of 1 or 2 g, twice daily for 4 to 7 days postoperatively
Number of subjects: 80
Study: 3818070

Group type: EXPERIMENTAL
Intervention: New support
Number of subjects: 144

Group type: COMPARATOR
Intervention: Double Tubigrip
Number of subjects: 144

Group type: COMPARATOR
Intervention: Eversion strapping
Number of subjects: 144
Study: 29618501

Group type: EXPERIMENTAL
Intervention: Microwell plate (MWP) version of the Roche HIV-1 Monitor test
Number of subjects: 1570

Group type: COMPARATOR
Intervention: Cobas version of the assay
Number of subjects: 1570
Study: 27137709

Group type: EXPERIMENTAL
Intervention: Positive psychology interventions (3 different 6-week face-to-face interventions)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 55
Study: 25164991

Group type: EXPERIMENTAL
Intervention: Studied items
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exemplar items
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Category-wide neural suppression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Item-specific neural suppression
Number of subjects: 0
Study: 22949162

Group type: EXPERIMENTAL
Intervention: Segmental neuromyotherapy combined with standard therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 24
Study: 20974574

Group type: EXPERIMENTAL
Intervention: Miconazole buccal tablet (MBT) 50 mg once daily
Number of subjects: 578

Group type: COMPARATOR
Intervention: Clotrimazole troches (CT) 10 mg 5 times daily
Number of subjects: 578
Study: 18838664

Group type: EXPERIMENTAL
Intervention: Phase-plane technique comparing each eye's velocity as a function of normalized displacement in patients with INO, oculomotor or abducens nerve palsy, and advanced extraocular muscle disease.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Phase-plane technique comparing each eye's velocity as a function of normalized displacement in patients with disease affecting the neuromuscular junction.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Phase-plane technique comparing each eye's velocity as a function of normalized displacement in patients with pontine lesions.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normal subjects making disconjugate saccades between two targets aligned on one eye.
Number of subjects: 22
Study: 15751170

Group type: EXPERIMENTAL
Intervention: docetaxel + cisplatin
Number of subjects: 0
Study: 12057879

Group type: EXPERIMENTAL
Intervention: Prospective preference assessment (PPA) method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional informed consent process
Number of subjects: 0